“We are very grateful for the generous funding support from Blue Buffalo and Pet Valu that is making this study possible,” said Patterson-Kane. If successful, researchers will explore the use of these markers to improve early diagnostics of mammary tumors in dogs. In previous human studies, increased expression of these cell markers in women was linked to mammary cancer. Melissa Meachem, will investigate the role of three cell markers in the progression of canine mammary cancer, from benign early lesions to aggressive cancer. University of Saskatchewan researchers, led by Dr. Janet Patterson-Kane, Morris Animal Foundation Chief Scientific Officer. “Mammary cancer continues to be a significant issue for dogs, but as with other cancers, earlier detection opens possibilities for significantly better treatment outcomes,” said Dr. Early detection, before the development of invasive and widespread disease, could greatly improve prognosis. Currently, there is no way to screen high-risk dogs for early mammary lesions - and up to 60% of these tumors already are malignant at the time of diagnosis. Mammary cancer is a common tumor diagnosis in intact female dogs. Pet Valu, located in Canada, and Blue Buffalo are funding partners on the project. DENVER/J– Morris Animal Foundation today announced it is funding a new study at the University of Saskatchewan, Canada, to develop improved diagnostic tools for detecting mammary cancer in dogs.
0 Comments
Leave a Reply. |